Literature DB >> 17438769

Serum concentrations of 11 polyfluoroalkyl compounds in the u.s. population: data from the national health and nutrition examination survey (NHANES).

Antonia M Calafat1, Zsuzsanna Kuklenyik, John A Reidy, Samuel P Caudill, Jason S Tully, Larry L Needham.   

Abstract

We measured the concentrations of 11 polyfluoroalkyl compounds (PFCs), including perfluorooctane sulfonic acid (PFOS), perfluorooctanoic acid (PFOA), and perfluorohexane sulfonic acid (PFHxS) in 1562 serum samples collected from a representative U.S. population 12 years of age and older in the 1999-2000 National Health and Nutrition Examination Survey. Participants represented both sexes, three race/ethnicities (non-Hispanic blacks, non-Hispanic whites, and Mexican-Americans), and four age categories (12-19 years, 20-39 years, 40-59 years, and 60 years and older). PFCs were extracted from 100 microL of serum using on-line solid-phase extraction coupled to isotope dilution-high performance liquid chromatography-tandem mass spectrometry; limits of detection ranged from 0.05 to 0.2 ng/ mL. PFOS, PFOA, PFHxS, and perfluorooctane sulfonamide were detected in all samples analyzed; 2-(N-ethyl-perfluorooctane sulfonamido) acetic acid, 2-(N-methyl-perfluorooctane sulfonamido) acetic acid, and perfluorononanoic acid were detected in more than 90% of samples, which suggests prevalent exposures to several PFCs in the U.S. population. The concentrations of most PFCs were similar regardless of the participants' ages but were higher in males than in females. Mexican Americans had lower concentrations than non-Hispanic blacks and non-Hispanic whites, whose concentrations were similar. Higher education was associated with higher concentrations of PFOS and PFOA. These data will serve as a nationally representative baseline of the U.S. population's exposure to PFCs to which other populations can be compared, and will play an important role in public health by helping set research priorities, ranging from health effects studies to defining sources and pathways of exposure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17438769     DOI: 10.1021/es062686m

Source DB:  PubMed          Journal:  Environ Sci Technol        ISSN: 0013-936X            Impact factor:   9.028


  122 in total

1.  Serum vaccine antibody concentrations in children exposed to perfluorinated compounds.

Authors:  Philippe Grandjean; Elisabeth Wreford Andersen; Esben Budtz-Jørgensen; Flemming Nielsen; Kåre Mølbak; Pal Weihe; Carsten Heilmann
Journal:  JAMA       Date:  2012-01-25       Impact factor: 56.272

2.  Perfluoroalkyl and polyfluoroalkyl substances and fetal thyroid hormone levels in umbilical cord blood among newborns by prelabor caesarean delivery.

Authors:  Ruxianguli Aimuzi; Kai Luo; Qian Chen; Hui Wang; Liping Feng; Fengxiu Ouyang; Jun Zhang
Journal:  Environ Int       Date:  2019-06-20       Impact factor: 9.621

3.  Prenatal and childhood exposure to per- and polyfluoroalkyl substances (PFASs) and child cognition.

Authors:  Maria H Harris; Emily Oken; Sheryl L Rifas-Shiman; Antonia M Calafat; Xiaoyun Ye; David C Bellinger; Thomas F Webster; Roberta F White; Sharon K Sagiv
Journal:  Environ Int       Date:  2018-04-26       Impact factor: 9.621

4.  Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis.

Authors:  Kaberi P Das; Carmen R Wood; Mimi T Lin; Anatoly A Starkov; Christopher Lau; Kendall B Wallace; J Christopher Corton; Barbara D Abbott
Journal:  Toxicology       Date:  2016-12-31       Impact factor: 4.221

5.  Effects of environmentally-relevant levels of perfluorooctane sulfonate on clinical parameters and immunological functions in B6C3F1 mice.

Authors:  Patricia A Fair; Erin Driscoll; Meagan A M Mollenhauer; Sarah G Bradshaw; Se Hun Yun; Kurunthachalam Kannan; Gregory D Bossart; Deborah E Keil; Margie M Peden-Adams
Journal:  J Immunotoxicol       Date:  2011-01-24       Impact factor: 3.000

6.  Decline in perfluorooctane sulfonate and perfluorooctanoate serum concentrations in an Australian population from 2002 to 2011.

Authors:  L-M L Toms; J Thompson; A Rotander; P Hobson; A M Calafat; K Kato; X Ye; S Broomhall; F Harden; J F Mueller
Journal:  Environ Int       Date:  2014-06-27       Impact factor: 9.621

7.  Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate.

Authors:  Claire Looker; Michael I Luster; Antonia M Calafat; Victor J Johnson; Gary R Burleson; Florence G Burleson; Tony Fletcher
Journal:  Toxicol Sci       Date:  2013-11-27       Impact factor: 4.849

8.  Polyfluorinated compounds in dust from homes, offices, and vehicles as predictors of concentrations in office workers' serum.

Authors:  Alicia J Fraser; Thomas F Webster; Deborah J Watkins; Mark J Strynar; Kayoko Kato; Antonia M Calafat; Verónica M Vieira; Michael D McClean
Journal:  Environ Int       Date:  2013-09-14       Impact factor: 9.621

9.  Perfluoroalkyl substances during pregnancy and validated preeclampsia among nulliparous women in the Norwegian Mother and Child Cohort Study.

Authors:  Anne P Starling; Stephanie M Engel; David B Richardson; Donna D Baird; Line S Haug; Alison M Stuebe; Kari Klungsøyr; Quaker Harmon; Georg Becher; Cathrine Thomsen; Azemira Sabaredzovic; Merete Eggesbø; Jane A Hoppin; Gregory S Travlos; Ralph E Wilson; Lill I Trogstad; Per Magnus; Matthew P Longnecker
Journal:  Am J Epidemiol       Date:  2014-02-20       Impact factor: 4.897

10.  Serum biomarkers of polyfluoroalkyl compound exposure in young girls in Greater Cincinnati and the San Francisco Bay Area, USA.

Authors:  Susan M Pinney; Frank M Biro; Gayle C Windham; Robert L Herrick; Lusine Yaghjyan; Antonia M Calafat; Paul Succop; Heidi Sucharew; Kathleen M Ball; Kayoko Kato; Lawrence H Kushi; Robert Bornschein
Journal:  Environ Pollut       Date:  2013-10-01       Impact factor: 8.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.